Metformin Increases Protein Phosphatase 2A Activity in Primary Human Skeletal Muscle Cells Derived from Lean Healthy Participants
Context. Skeletal muscle insulin resistance is one of the primary contributors of type 2 diabetes (T2D). Metformin is the first-line drug for the treatment of T2D. The primary effects of metformin include decreasing glucose production in the liver and decreasing insulin resistance in the skeletal mu...
Saved in:
Main Authors: | Aktham Mestareehi, Xiangmin Zhang, Berhane Seyoum, Zaher Msallaty, Abdullah Mallisho, Kyle Jon Burghardt, Anjaneyulu Kowluru, Zhengping Yi |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2021-01-01
|
Series: | Journal of Diabetes Research |
Online Access: | http://dx.doi.org/10.1155/2021/9979234 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Skeletal Muscle Physiology
by: Lucas Guimarães-Ferreira, et al.
Published: (2013-01-01) -
Protein tyrosine phosphatase delta is a STAT3-phosphatase and suppressor of metabolic liver disease
by: Thomas F Baumert, et al.
Published: (2025-01-01) -
Skeletal Muscle Mitochondria and Aging: A Review
by: Courtney M. Peterson, et al.
Published: (2012-01-01) -
Tissue Engineered Strategies for Skeletal Muscle Injury
by: Umile Giuseppe Longo, et al.
Published: (2012-01-01) -
Single-Molecule Analysis of Alkaline Phosphatase
by: Douglas B. Craig
Published: (2024-10-01)